Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Results 1-8 of 8 for your search
Show Search Criteria
Combination Chemotherapy with or without Temsirolimus in Treating Patients with Intermediate Risk Rhabdomyosarcoma
Status: Active
Age: 40 years and under
Gender: Male or Female
Location: 287 locations
Vorinostat and Temsirolimus with or without Radiation Therapy in Treating Younger Patients with Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma
Status: Active
Age: 7 months to 21 years
Gender: Male or Female
Location: M D Anderson Cancer Center, Houston, Texas
Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients with Advanced, Recurrent, or Refractory Solid Tumors
Status: Active
Age: 1 to 20 years
Gender: Male or Female
Location: M D Anderson Cancer Center, Houston, Texas
Bevacizumab and Temsirolimus Alone or in Combination with Valproic Acid or Cetuximab in Treating Patients with Advanced or Metastatic Malignancy or Other Benign Disease
Status: Active
Age: Not specified
Gender: Male or Female
Location: M D Anderson Cancer Center, Houston, Texas
Temsirolimus and Metformin Hydrochloride in Treating Patients with Advanced or Metastatic Cancer
Status: Active
Age: 14 years and over
Gender: Male or Female
Location: M D Anderson Cancer Center, Houston, Texas
Risk-Based Therapy in Treating Younger Patients with Newly Diagnosed Liver Cancer
Status: Temporarily Closed to Accrual
Age: 21 years and under
Gender: Male or Female
Location: 167 locations